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The world’s most successful intracellular bacterial pathogen, Mycobacterium tuberculosis
(MTB), survives inside macrophages by blocking phagosome maturation and establishes
chronic infection characterized by the formation of granulomas. Trehalose-6,6-dimycolate
(TDM), the mycobacterial cord factor, is the most abundant cell wall lipid of virulent
mycobacteria, is sufficient to cause granuloma formation, and has long been known to be
a major virulence factor of MTB. Recently, TDM has been shown to activate the Syk-Card9
signaling pathway in macrophages through binding to the C-type lectin receptor Mincle.
The Mincle-Card9 pathway is required for activation of macrophages by TDM in vitro and
for granuloma formation in vivo following injection of TDM. Whether this pathway is also
exploited by MTB to reprogram the macrophage into a comfortable niche has not been
explored yet. Several recent studies have investigated the phenotype of Mincle-deficient
mice in mycobacterial infection, yielding divergent results in terms of a role for Mincle in
host resistance. Here, we review these studies, discuss possible reasons for discrepant
results and highlight open questions in the role of Mincle and other C-type lectin receptors
in the infection biology of MTB.
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TDM’s HISTORY AS PAMP AND GLYCOLIPID EFFECTOR
MOLECULE OF MYCOBACTERIA
Trehalose-6,6-dimycolate (TDM) has been isolated as a major
glycolipid from the cell wall of pathogenic mycobacteria in the
1950s by Bloch and colleagues (see Hunter et al., 2006 for
review). The biological properties of TDM have been explored
in vivo using mice and rabbit models and led to the realiza-
tion that TDM is sufficient to induce formation of granulomas
when injected in oil doplets (Yarkoni and Rapp, 1977; Ishikawa
et al., 2009). These data indicated that TDM per se triggers
an important reaction to mycobacterial infection, which has
traditionally been viewed as a correlate of protective immune
responses, required to wall off infection. TDM also possesses
adjuvant properties and is contained in the experimental adju-
vant Ribi (Gavin et al., 2006). While these properties of TDM
indicated that it acted as a pathogen-associated molecular pattern
(PAMP), indicatingmicrobial danger and alerting innate immune
cells, the cord factor has also been recognized since so long as
a virulence factor of mycobacteria (Figure 1). First, extraction
of glycolipids with petroleum ether from the cell wall of MTB
rendered the mycobacteria avirulent, due to efficient killing of
the TDM-less mycobacteria inside macrophages (Indrigo et al.,
2002, 2003). Second, when replacing this rough and crippling
procedure with genetic ablation of TDM biosynthesis, the atten-
uated phenotype was confirmed in fbpA mutants lacking
the mycolic acid transferase antigen 85A (Katti et al., 2008).
In addition, these mutants triggered enhanced production of
inflammatory cytokines and increased antigen presentation from
infected macrophages (Kan-Sutton et al., 2009). Third, TDM
coated onto beads is sufficient to delay phagosome matura-
tion in macrophages (Axelrod et al., 2008), whereas the mutant
MTB lacking TDM failed to block phagosome maturation (Katti
et al., 2008). Together, the cord factor qualifies as a glycolipid
effector molecule of pathogenic mycobacteria that reprograms
macrophages for mycobacterial immune evasion and creation of
a niche in the phagosome.
TDM AS PAMP
A ROLE FOR TLR?
Despite the decade-long knowledge of the inflammatory capaci-
ties of the cord factor, the mechanisms of immune cell activation
by TDM were elusive until recently. As an abundant mycobac-
terial cell wall glycolipid with a chemical structure not found
in vertebrate organisms, TDM a priori qualifies as a prototypi-
cal PAMP that may signal the presence of mycobacterial danger
to innate immune cells. The phenocopying of inflammatory
and granulomatous responses-induced by whole mycobacteria
by TDM in animal models, and its long known property as an
adjuvant eliciting cellular immune responses to co-administered
protein antigen, support the notion of TDM being a PAMP. After
the discovery of the toll-like receptor (TLR) family and several
mycobacterial ligands that are recognized by TLR family members
(ManLAM, 19 kDa lipopeptide), the search for a pattern recogni-
tion receptor sensing TDM naturally first focused on a potential
role of TLR. In Geisel et al. (2005) reported that TDM-coated
beads stimulated TNF and IL-6 production by macrophages
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FIGURE 1 | TDM between PAMP and effector molecule.
in vitro, and that TDM in gel matrices injected s.c. into mice trig-
gered massive leukocyte infiltration (Geisel et al., 2005). The role
of TLR2 and TLR4, and of the adapter proteinMyd88, was investi-
gated exclusively for the in vivo leukocyte recruitment but not for
the macrophage cytokine response in vitro. While TLR2−/− and
TLR4−/− mice had no defect in leukocyte recruitment to TDM
gel matrices, Myd88-deficient mice showed a severe reduction,
pointing to a possible role for other TLRs or of other Myd88-
utilizing receptors, e.g., for the cytokines IL-1 or IL-18. This initial
report from the Russell lab was followed by a study reporting
that murine macrophages deficient in TLR2 and in TLR4 had
a strongly reduced response to TDM (Bowdish et al., 2009). In
addition, the scavenger receptor MARCO was suggested to bind
TDM in this study. Since scavenger receptors lack a cytoplasmic
domain and are usually endocytic clearance receptors rather than
activating PRR, a model was proposed where MARCO binding
of TDM serves as a prerequisite for delivery to and activation of
TLRs (Bowdish et al., 2009). In this context, a previous study is
also of interest that investigated macrophages lacking Scavenger
receptor A (SR-A) in vitro and observed an increased inflamma-
tory response; importantly, these authors reported also that SR-A
bound to the cord factor (Ozeki et al., 2006).
TDM ACTIVATES MINCLE-Syk-Card9 SIGNALING
Our own studies first aimed at determining a role of the TLR
pathway for macrophage and DC activation-induced by TDM
and its synthetic analog TDB. We observed that bone mar-
row derived macrophages from mice lacking Myd88 responded
comparably to wild type cells (Werninghaus et al., 2009). In addi-
tion, the adjuvant activity of the cord factor analog TDB was
preserved in mice deficient in TLR2, TLR3, TLR4, and TLR7
(Agger et al., 2008). This apparent lack of TLR-dependence led
us to consider other PRR pathways. At this time, the C-type
lectin receptor Dectin-1 (Brown, 2006) had just been described
to activate macrophages via Syk-Card9 signaling (Gross et al.,
2006). We employed macrophages from the respective KO mice
to genetically define that macrophage activation by TDB and
TDM requires Syk-Card9-Bcl10-Malt1 signaling, but is inde-
pendent of Dectin-1 (Werninghaus et al., 2009). In contrast to
Dectin-1 with its intracellular non-classical ITAM motif, other
CLR activate Syk via association with an adapter protein car-
rying the classical ITAM motif (Robinson et al., 2006). The
requirement for the adapter protein FcRg but not Dap12 pointed
to a certain set of C-type lectin receptors, including the fam-
ily member Mincle (gene symbol: Clec4e) that was expressed
inducibly in macrophages stimulated with the glycolipids. Mincle
had been described in 2008 by Yamasaki et al. as sensor of necro-
sis that binds SAP130, a splicing factor released from dying cells
(Yamasaki et al., 2008). Using independent lines of Mincle KO
mice, Yamasaki et al. and Wells et al. demonstrated a function
of Mincle in the recognition of fungal carbohydrates in the cell
wall of Candida andMalassezia yeast (Wells et al., 2008; Yamasaki
et al., 2009). A role for Mincle in recognition of mycobacteria
was suggested by Yamasaki’s group through experiments using
a Mincle-reporter cell line. In a series of elegant experiments,
they then identified the TDM from cell wall lipid fractionations
as the active compound, showed direct binding of Mincle to
TDM, and demonstrated that Mincle−/− mice fail to produce
the granulomatous response to TDM observed in the lungs of
wild-type mice (Ishikawa et al., 2009). In parallel, experiments
with Mincle-deficient mice in our lab showed that TDB and TDM
do not activate macrophages from these mice anymore and that
the Th1/Th17 adjuvant effect of TDB requires Mincle in vivo
(Schoenen et al., 2010). Together, these studies provided solid
evidence that Mincle is an essential receptor for the mycobacte-
rial cord factor (Matsunaga and Moody, 2009) (Figure 2). Until
now, however, the requirement for Mincle in TDM recognition
has only been shown in the mouse system, and the possibility
that the response to the cord factor in human macrophages is
mediated by the same receptor and pathway remains to be proven
experimentally (Lang et al., 2011).
POTENTIAL FOR SYNERGY AND CROSS-REGULATION OF TLR AND
MINCLE SIGNALING
The reasons for the discordant results concerning the involve-
ment of TLR-Myd88 signaling for TDM recognition between the
Bowdish et al. (2009) and our studies (Werninghaus et al., 2009;
Schoenen et al., 2010) are at present unclear. Differences in the
type of macrophage used (bone marrow derived vs. resident peri-
toneal macrophages), culture conditions, and the presentation of
Frontiers in Immunology | Inflammation January 2013 | Volume 4 | Article 5 | 2
Lang TDM recognition by C-type lectin receptors
FIGURE 2 | TDM recognition and responses through regulated Mincle expression: possible synergy with TLR signals.
TDM (coated onto the cell culture dish vs. presented on beads)
may be responsible. In general, TLR and CLR pathways can
synergize to activate gene expression in macrophages. This has
been clearly shown in the case of zymosan-triggered activation of
macrophages through Dectin-1 and TLR2 (Dennehy et al., 2008,
2009). In the case of Mincle-mediated recognition of the cord
factor, the inducible expression of the Mincle receptor following
stimulation with TLR ligands (Matsumoto et al., 1999) suggests a
mechanism of priming of macrophages for increased sensitivity
to the CLR ligand TDM (Figure 2). The role of the MARCO-
TLR2-Myd88 pathway described by Bowdish et al. for TDM
recognition (Bowdish et al., 2009) may therefore consist in licens-
ing of macrophages for TDM responsiveness through induction
of Mincle expression. A synergistic effect of Myd88 and Mincle
for TDM responsiveness has very recently been shown for neu-
trophils by Lee et al. (2012): Myd88−/− neutrophils responded
equally well with TNF release and adhesion to TDM as WT;
in contrast, upon combined treatment with the TLR2 ligand
Pam3CSK and TDM, synergistic induction was observed in WT
but not Myd88−/− neutrophils, creating a significantly reduced
response in Myd88−/− vs. wild-type neutrophils that correlated
with a lack of up-regulation of Mincle in the Myd88−/− cells (Lee
et al., 2012).
IS MINCLE REQUIRED FOR ANTI-MYCOBACTERIAL
IMMUNITY? CONTRADICTORY ANSWERS FROM
MOUSE INFECTION MODELS
While the identification of Mincle as receptor for the cord factor
solved a longstanding issue in TB research and provided a molec-
ular basis for the adjuvant effect of TDM and TDB, the medically
most important question remains whether Mincle and its asso-
ciated pathway are required for anti-mycobacterial immunity, or
may to the contrary be used by the pathogen to subvert immune
responses.
In vitro STUDIES WITH PHAGOCYTES
The first steps taken to address the importance of the Mincle-
Syk-Card9 pathway in the dealing of innate immune cells with
infecting mycobacteria were in vitro infection experiments of
macrophages with M. bovis BCG or MTB. These experiments
showed a differential requirement for Mincle-signaling in the
expression of several genes-induced by mycobacterial infection.
Mincle-deficient macrophages expressed 10-fold less G-CSF and
IL-6 in response to BCG (Schoenen et al., 2010). More recently,
Behler et al. confirmed the essential role of Mincle for inflam-
matory cytokine and chemokine production in response to BCG
in alveolar macrophages (Behler et al., 2012). Ishikawa et al.
observed a slight reduction in the levels of several chemokines
in Mincle−/− macrophages infected with MTB; this dependence
on Mincle was strongly enlarged when macrophages from a
Myd88−/− background were used (Ishikawa et al., 2009). Thus,
a picture emerges that in the absence of Mincle macrophages can
still sense mycobacteria through recognition of PAMPs other than
TDM, but the inflammatory response is compromised at least for
a subset of response genes. To date no published data is available
that has tested whether phagocytosis of mycobacteria is reduced
or delayed in Mincle−/− macrophages.
In vivo MYCOBACTERIAL INFECTION MODELS
To date, three publications have reported on experimental
mycobacterial infection in Mincle−/− mice (Behler et al., 2012;
Heitmann et al., 2012; Lee et al., 2012) (see Table 1). Heitmann
et al. used aerosol infection with MTB H37Rv and comprehen-
sively analysed bacterial burden in lung and spleen, as well as
the inflammatory and T cell responses in the lungs and drain-
ing lymph nodes at three different time points after infection.
In addition, histopathological analysis of the lungs for the extent
of infiltration, granulomatous response and immunocytochem-
istry for iNOS expression was performed. None of these readouts
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Table 1 | C-type lectin receptors in mycobacterial infection.
Dectin-1 Mincle Signr3
Mycobacterial ligand Unknown TDM ManLAM
Expression of CLR Macrophages and DC Inducible in macrophages and DC;
High constitutive expression in
granulocytes
Up-regulated in alveolar
macrophages during infection
Phenotype of knockout mouse
in mycobacterial infection
Slightly reduced bacterial load
in the lung;
Unchanged adaptive immune
response
Increased bacterial dissemination
after BCG infection (Behler et al.,
2012);
Increased pulmonary load after
MTB Erdman (Lee et al., 2012);
Unchanged resistance after MTB
H37Rv (Heitmann et al., 2012)
Increased mycobacterial load early
in infection;
Intact adaptive immune responses
References Marakalala et al. (2011) Behler et al. (2012); Heitmann
et al. (2012); Lee et al. (2012)
Tanne et al. (2009)
showed a significant difference between Mincle−/− and WT con-
trol mice, leading to the conclusion that Mincle is not essential
for the host response and protection against TB infection in mice.
Low-dose aerosol infection with MTB is arguably the best mouse
model for human TB; however, there are examples of knockout
mice where the deletion of a gene did not cause a phenotype in the
low dose model, but mice showed higher bacterial burden when
challenged with a higher dose or by a different route (Reiling et al.,
2002). To test for this possibility, Heitmann et al. also challenged
Mincle−/− mice with a high dose of MTB H37Rv, again with no
discernible difference in the bacterial load.
The second study reporting on the phenotype of Mincle−/−
mice in MTB is the paper by Lee et al., who focused their interest
on the expression and function of Mincle in neutrophilic gran-
ulocytes during in vivo and in vitro encounter with TDM (Lee
et al., 2012). Corroborating and extending the results obtained
by Yamasaki’s group (Ishikawa et al., 2009), they showed that
Mincle−/− mice fail to mount a granulomatous response to
intravenously injected TDM and that Mincle expression on neu-
trophils is required for recruitment to TDM-coated beads injected
subcutaneously. They further demonstrate that neutrophils attach
to plate-bound TDM in vitro and respond in a Mincle-dependent
manner with up-regulation of integrins and production of reac-
tive oxygen species. These results are interesting because they
draw attention to neutrophils which express higher levels of
Mincle than macrophages and can immediately respond to TDM.
Lee et al. also demonstrate that depletion of neutrophils with an
anti-Ly6G antibody reduced the initial granulomatous response
and the levels of IL-6 and MCP-1 in the lungs of TDM-injected
mice. The analysis of MTB infection in the Mincle−/− mice in
the study by Lee et al. consists of one low-dose aerosol infec-
tion experiment where bacterial loads in the lungs were deter-
mined at two time-points after infection, showing a significant
but moderate increase (0.5 log10). The increased mycobacterial
numbers in the Mincle−/− mice were paralleled by a stronger
expression of inflammatory genes in the lungs. Given the expres-
sion and function of Mincle in granulocytes described in the
same paper, it would be interesting to know whether neutrophil
accumulation, integrin expression and cytokine production in
the lungs is particularly affected in the mice infected in the
Lee et al. study. The higher expression of inflammatory genes
in Mincle−/− lungs is difficult to interpret because it could be
entirely due to the increased mycobacterial load generating more
PAMPs for activation of receptors other than Mincle. One can
only speculate at which time after infection Mincle−/− mice start
to have higher MTB burden in the lung; one possibility is that
a lack of recruitment and proper activation of neutrophils early
after infection gives MTB the ability to survive and grow better
than in WT mice.
In contrast, the third study, reported by Behler et al., used
the vaccine strain M. bovis BCG in intratracheal and intra-
venous infection models (Behler et al., 2012). These authors first
characterized the expression of Mincle on alveolar macrophages
following exposure to BCG in vivo, and observed a strong up-
regulation of receptor levels on the cell surface. This is consistent
with previous observations in vitro at the mRNA and protein
level (Yamasaki et al., 2008; Werninghaus et al., 2009; Schoenen
et al., 2010), and importantly it first demonstrates that this pro-
cess occurs during mycobacterial encounter in vivo, implying that
Mincle induction by mycobacterial signals could serve to bolster
recognition and defense against spread of mycobacteria or sec-
ondary challenge by subsequent exposure. In fact, this is exactly
what the authors found in their further experiments: when mice
were infected twice with BCG separated by 14 days, the inflamma-
tory response to BCG in the airways and in alveolar macrophages
strongly increased in a Mincle-dependent fashion. More impor-
tantly, the priming infection increased the Mincle-dependence
of BCG-growth restriction, showing that the up-regulation of
Mincle during the priming period indeed led to better innate con-
trol of intruding mycobacteria by alveolar macrophages. Another
interesting effect of Mincle-deficiency in this study is the stronger
increase in the bacterial burden in the draining lymph nodes
and the spleen, compared to the lungs after intratracheal BCG
infection (Behler et al., 2012). Dissemination of BCG after airway
infection requires time until pulmonary mycobacteria have suffi-
ciently expanded, allowing the quite slow induction of Mincle on
alveolar macrophages (and also on other recruited cells, e.g., neu-
trophils) to generate the higher capacity of BCG recognition and
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to mount a better response leading to containment of infection at
the local site.
Taken together, these recent studies on the role of Mincle in
the host response to mycobacterial infection yielded remarkably
different results, raising the question for possible reasons that
underlie the discrepant findings.
First, the three studies used different strains of M. tubercu-
losis (H37Rv in the Heitmann et al., Erdman in the Lee et al.
study) or employed the vaccine strain M. bovis BCG (Behler
et al.). Although all these strains have abundant TDM in the
cell wall, they may differ in the length of mycolic acid chains,
modifications and the mixture of other glycolipids present in the
cell wall, which may account for the difference in the require-
ment for Mincle. Of interest, in vitro infection experiments of
macrophages showed a stronger dependence of the NO produc-
tion and of G-CSF secretion on Mincle when BCG was used
compared to MTBH37Rv (Heitmann et al., 2012), which appears
consistent with the larger role of Mincle in BCG vs. MTB H37Rv
infection.
The relative amount of TDM present in the mycobacterial cell
may also be affected by glycolipid exchange through the action
of mycolyltransferases. Increased levels of glucose, as they are
encountered by the mycobacteria in the cellular growth environ-
ment, can lead to a shift in glycolipid synthesis from TDM to
glucose monomycolate (GMM) in an Ag85A-dependent manner
(Matsunaga et al., 2008). GMM is a ligand for CD1b in humans
(Moody et al., 1997), it has not been formally tested for binding
to and activation of Mincle.
In principle, another variable can be introduced by changes
in the culture conditions used to grow the mycobacteria before
infection. For example, the commonly used inclusion of deter-
gents like Tween in the mycobacterial broth to prevent clumping
has been shown to drastically modify the presence of a polysac-
charide capsular structure (Sani et al., 2010) and may also wash
out TDM from the mycobacterial cell wall. Indeed, the inclu-
sion of Tween in ELISA wash buffers can even remove coated
glycolipids from microtiter plate plastic (Julian et al., 2001) and
drastically reduce the detection of TDM-specific antibodies from
the sera of TB patients (Traunmuller et al., 2005). It is therefore
conceivable that inter-strain differences and subtle changes in the
culture conditions used can significantly affect the composition
of the mycobacterial cell wall and capsule, thereby affecting the
interaction with Mincle and other pattern recognition receptors
and changing the outcome of infection.
Finally, the hygiene status ofmouse colonies can be expected to
alter the basal levels of innate immune activation in general and
of Mincle expression levels on phagocytes in particular through
effects of TLR- and CLR-dependent PAMPs.
ROLE OF OTHER C-TYPE LECTIN RECEPTORS IN
ANTI-MYCOBACTERIAL IMMUNITY
The adapter protein Card9 is expressed in myeloid cells and was
initially identified as crucial for transducing the signal of the
C-type lectin receptor Dectin-1 to NFkB activation (Gross et al.,
2006). Card9 is down-stream of Syk and becomes phosphorylated
by PKC delta (Strasser et al., 2012). Card9 is not only required for
Dectin-1 signaling, but is also the central adapter for DAP12- and
FcRγ-chain-coupled C-type lectin receptors likeMincle, Dectin-2
and Clec5a (Hara et al., 2007; Yamasaki et al., 2008; Werninghaus
et al., 2009). Dorhoi et al. showed that the absence of Card9 ren-
ders mice exquisitely sensitive to infection with MTB (Dorhoi
et al., 2010). Following aerosol infection, Card9−/− mice develop
high mycobacterial burden in the lungs and die within 4–6 weeks.
Card9−/− macrophages normally phagocytosed and killed MTB
in vitro, but were impaired in the production of inflamma-
tory cytokines and chemokines. In vivo, Card9−/− mice had a
striking increase in neutrophil infiltration in the lung that was
linked to tissue destruction and death of the mice by deple-
tion experiments (Dorhoi et al., 2010). This essential role of
Card9 in anti-mycobacterial defense, together with the relative
lack of a phenotype in Mincle-deficient mice, poses the question
which other C-type lectin receptors signaling through Card9 are
triggered during MTB infection (see Table 1).
Dectin-1 has been implicated by several labs in the response to
mycobacteria, but the nature of the ligand has remained unknown
to date. Blocking Dectin-1 with antibodies or laminarin reduced
cytokine responses to M. bovis BCG or MTB (Yadav and Schorey,
2006; Rothfuchs et al., 2007). In addition, a reduced uptake
of M. abscessus and impaired ROS production was reported
when Dectin-1 was blocked in mouse macrophages (Shin et al.,
2008). To test the contribution of Dectin-1-mediated recogni-
tion of mycobacteria in vivo, Brown and colleagues challenged
Dectin-1 KO mice with virulent MTB. The mycobacterial load
in the lungs was unexpectedly slightly reduced in Dectin-1 KO
mice, but there were no significant differences in lung pathology
or adaptive immune responses (Marakalala et al., 2011). Thus,
Dectin-1 appears to play a rather redundant role for protection
against MTB.
The human C-type lectin DC-SIGN has received considerable
attention in the mycobacterial immunity field when it was dis-
covered that binding of mycobacterial Man-LAM to DC-SIGN
on humanmacrophages down-regulates costimulatory molecules
and inflammatory responses, presumably via induction of IL-10
production (Geijtenbeek et al., 2003). There are several murine
homologues of human DC-SIGN in a cluster of seven genes
and one pseudogene (Tanne et al., 2009). Based on the bind-
ing to glycans with high mannose content and fucose-containing
oligosaccharides, mouse SIGNR3 is the best candidate as ortholog
for human DC-SIGN. Tanne et al. created knockout mice for
Signr1, Signr3 and Signr5, and determined their phenotype in TB
infection (Tanne et al., 2009). The mycobacterial load in the lungs
of Signr3-deficient mice was clearly increased, whereas knockout
mice for Signr1 and Signr5 were indistinguishable from wild-
type controls. However, the development of adaptive immune
response to TB was not compromised in the absence of SIGNR3
and the mice did not die at higher rates compared to controls of
TB. Of note, SIGNR3 was up-regulated on lung phagocytic cells
during infection, and the increased mycobacterial load was spe-
cific for the lung while no difference between WT and Signr3−/−
mice was seen in the spleen. SIGNR3 binding of ManLAM
and whole mycobacteria induces production of proinflammatory
cytokines through activation of Syk and the kinase Raf1 (Tanne
et al., 2009). Although the requirement for Card9 in the activation
of macrophages and DC in response to ligation of SIGNR3
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has not been formally demonstrated, it appears very likely. Hence,
a defect in the signaling of SIGRNR3 may contribute to the
strong phenotype of the Card9−/− mice in tuberculosis, although
it appears to be essential for anti-mycobacterial resistance only
during the early innate phase of infection.
Given the large number of CLR that can be expressed in
myeloid cells, additional playersmust be expected to contribute to
recognition of mycobacterial ligands and to macrophage activa-
tion and anti-mycobacterial defense via Card9-dependent mech-
anisms. Another interesting candidate to look at is Dectin-2;
of note a Dectin-2-Fc fusion protein binds to the surface of
mycobacteria (McGreal et al., 2006). Similar to Mincle, Dectin-2
utilizes the FcRγ chain as adapter molecule. Interestingly, FcRγ
chain-deficient mice develop increased mycobacterial burden,
enhanced immunpathology and earlier death when challenged
with MTB (Maglione et al., 2008). While Chan and colleagues
discuss their findings exclusively in the context of FcRγ chain’s
role as adapter of activating Fc gamma receptors mediating anti-
body effector function, the dual use of the adapter in recruiting
Syk also to several CLR family members could also indicate
that the phenotype is at least in part due to a lack of signal-
ing by Mincle, Dectin-2 and other CLRs. Likewise, the activation
of the FcRγ-Syk-Card9 signaling cascade by Fc gamma recep-
tors would allow a contribution of antibody-mediated effects to
Card9-dependent protection in TB infection, a possibility that has
not been explored to date.
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